Home ›
Entities
› academia
› Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma
Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma
Research article (Translational Oncology, 2024) · cited 11× · AI/ML
Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma
Summary
Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma is a scholarly article[1].
Key Facts
Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma. Retrieved May 24, 2026, from https://4ort.xyz/entity/machine-learning-developed-an-intratumor-heterogeneity-signature-for-predicting-prognosis-and-immunotherapy-benefits-in-
MLA“Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/machine-learning-developed-an-intratumor-heterogeneity-signature-for-predicting-prognosis-and-immunotherapy-benefits-in-.
BibTeX@misc{4ortxyz_machine-learning-developed-an-intratumor-heterogeneity-signature-for-predicting-prognosis-and-immunotherapy-benefits-in-_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma}}, year = {2026}, url = {https://4ort.xyz/entity/machine-learning-developed-an-intratumor-heterogeneity-signature-for-predicting-prognosis-and-immunotherapy-benefits-in-}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma — https://4ort.xyz/entity/machine-learning-developed-an-intratumor-heterogeneity-signature-for-predicting-prognosis-and-immunotherapy-benefits-in- (retrieved 2026-05-24)
